Literature DB >> 8018114

Practicalities of once-daily aminoglycoside dosing.

S E Parker1, P G Davey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8018114     DOI: 10.1093/jac/31.1.4

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

1.  Once-daily dosing of aminoglycosides.

Authors:  J Blaser; C König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

Review 2.  Once-daily aminoglycoside administration in gram-negative sepsis. Economic and practical aspects.

Authors:  S E Parker; P G Davey
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

Review 3.  Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?

Authors:  M L Barclay; C M Kirkpatrick; E J Begg
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

4.  Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.

Authors:  D J Demczar; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Cost of gentamicin assays carried out by microbiology laboratories.

Authors:  P F Vacani; M M Malek; P G Davey
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

6.  A suggested approach to once-daily aminoglycoside dosing.

Authors:  E J Begg; M L Barclay; S B Duffull
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

7.  Pharmacokinetic and pharmacodynamic approach for comparing two therapeutic regimens using amikacin.

Authors:  M Staneva; B Markova; I Atanasova; D Terziivanov
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

8.  Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.

Authors:  Jean-Marie Conil; Bernard Georges; Stéphanie Ruiz; Thomas Rival; Thierry Seguin; Pierre Cougot; Olivier Fourcade; Georges Houin Pharmd; Sylvie Saivin
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

9.  Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.

Authors:  M M McFarland; E M Scott; A Li Wan Po
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 10.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.